Name | (3S)-N-[2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2H-chromene-3-carboxamide |
---|---|
Synonyms |
CS-0775
ROCK-II inhibitor Chroman 1 |
Description | Chroman 1 is a highly potent ROCK2 inhibitor, with an IC50 of 1 nM. |
---|---|
Related Catalog | |
Target |
ROCK2:1 nM (IC50) MRCK:150 nM (IC50) |
In Vitro | Chroman 1 is a highly potent ROCK2 inhibitor, with an IC50 of < 1 nM. Chroman 1 also shows inhibitory activities against MRCK, with an IC50 of 150 nM, but has no effect on PKA (IC50, > 20000 nM) or AKT1 (IC50, > 20000 nM)[1]. |
Kinase Assay | Assays are performed using the HTRF KinEASE STK S2 kit. A 5 μL mixture of 1 μM STK2 substrate and 20 μM ATP in STK-buffer is added to the wells. Inhibitor (including Chroman 1, 20 nL) at various concentrations is then dispensed. Reaction is started by addition of 0.5 nM ROCK-II in STK-buffer (5 μL). After 4 h at room temperture (rt), the reaction is stopped by addition of 10 μL mixture of 1× STK antibody-Cryptate in detection buffer and 62.5 nM Sa-XL in detection buffer. After 1 h at rt, the plates are read on the Viewlux in HTRF mode[1]. |
References |
Molecular Formula | C24H28N4O4 |
---|---|
Molecular Weight | 436.50400 |
Exact Mass | 436.21100 |
PSA | 92.20000 |
LogP | 3.86500 |
Storage condition | 2-8℃ |